PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BlackRock Health Sciences Trust (BME)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS09250W1071
CUSIP09250W107
SectorFinancial Services
IndustryAsset Management
IPO DateMar 29, 2005

Highlights

Market Cap$557.14M
EPS (TTM)$3.93
PE Ratio10.43
Total Revenue (TTM)$22.35M
Gross Profit (TTM)$16.24M
EBITDA (TTM)$54.68M
Year Range$35.19 - $42.21
Short %0.06%
Short Ratio0.26

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: BME vs. BMEZ, BME vs. VHT, BME vs. BUI, BME vs. STRGX, BME vs. FDUS, BME vs. VOO, BME vs. VNQ, BME vs. BST, BME vs. SPY, BME vs. XLE

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in BlackRock Health Sciences Trust, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
3.97%
12.99%
BME (BlackRock Health Sciences Trust)
Benchmark (^GSPC)

Returns By Period

BlackRock Health Sciences Trust had a return of 5.88% year-to-date (YTD) and 14.73% in the last 12 months. Over the past 10 years, BlackRock Health Sciences Trust had an annualized return of 7.89%, while the S&P 500 had an annualized return of 11.39%, indicating that BlackRock Health Sciences Trust did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date5.88%25.48%
1 month-3.25%2.14%
6 months3.84%12.76%
1 year14.73%33.14%
5 years (annualized)6.21%13.96%
10 years (annualized)7.89%11.39%

Monthly Returns

The table below presents the monthly returns of BME, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20243.04%1.81%-0.88%-4.94%2.36%2.95%1.18%3.67%-0.63%-4.28%5.88%
20230.45%-3.12%0.22%3.08%-6.51%2.32%-1.00%0.38%-1.50%-7.07%6.96%5.71%-1.08%
2022-6.59%-3.77%5.93%-4.28%1.47%-2.64%3.86%-5.31%-5.50%9.92%5.41%-1.63%-4.63%
20211.02%-4.08%1.56%4.31%0.06%1.76%0.95%-0.10%-1.37%1.18%-3.12%5.25%7.25%
2020-2.79%-8.48%-3.18%11.97%6.36%-3.56%5.29%2.02%-0.77%-2.27%11.27%3.46%18.64%
20199.40%1.62%-0.30%-3.35%-4.88%8.00%0.90%-2.39%1.43%2.72%7.14%2.52%24.04%
2018-0.25%-2.46%0.24%0.60%5.61%5.47%4.19%4.57%2.69%-10.21%9.49%-11.51%6.38%
20174.94%3.88%1.73%1.75%0.52%5.40%0.82%-1.56%1.92%-0.72%1.41%1.11%23.10%
2016-9.29%-1.27%2.31%3.88%4.43%-5.89%1.90%-3.12%-0.64%-4.16%4.69%-4.57%-12.15%
2015-2.13%2.08%2.02%-4.37%7.96%-2.48%4.70%4.58%-18.82%9.95%3.51%4.70%8.69%
2014-1.58%10.46%-2.85%-3.95%2.77%1.73%-2.01%4.33%2.60%9.11%12.72%-1.97%34.12%
20136.32%2.58%2.77%0.64%2.27%-1.50%7.24%-2.40%1.39%2.91%1.79%11.29%40.59%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BME is 74, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of BME is 7474
Combined Rank
The Sharpe Ratio Rank of BME is 7777Sharpe Ratio Rank
The Sortino Ratio Rank of BME is 7070Sortino Ratio Rank
The Omega Ratio Rank of BME is 7070Omega Ratio Rank
The Calmar Ratio Rank of BME is 7676Calmar Ratio Rank
The Martin Ratio Rank of BME is 7474Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for BlackRock Health Sciences Trust (BME) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


BME
Sharpe ratio
The chart of Sharpe ratio for BME, currently valued at 1.32, compared to the broader market-4.00-2.000.002.004.001.32
Sortino ratio
The chart of Sortino ratio for BME, currently valued at 1.83, compared to the broader market-4.00-2.000.002.004.006.001.83
Omega ratio
The chart of Omega ratio for BME, currently valued at 1.24, compared to the broader market0.501.001.502.001.24
Calmar ratio
The chart of Calmar ratio for BME, currently valued at 1.11, compared to the broader market0.002.004.006.001.11
Martin ratio
The chart of Martin ratio for BME, currently valued at 4.87, compared to the broader market0.0010.0020.0030.004.87
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.91, compared to the broader market-4.00-2.000.002.004.002.91
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.88, compared to the broader market-4.00-2.000.002.004.006.003.88
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.501.001.502.001.55
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 4.20, compared to the broader market0.002.004.006.004.20
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 18.80, compared to the broader market0.0010.0020.0030.0018.80

Sharpe Ratio

The current BlackRock Health Sciences Trust Sharpe ratio is 1.32. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of BlackRock Health Sciences Trust with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
1.32
2.91
BME (BlackRock Health Sciences Trust)
Benchmark (^GSPC)

Dividends

Dividend History

BlackRock Health Sciences Trust provided a 5.76% dividend yield over the last twelve months, with an annual payout of $2.34 per share. The company has been increasing its dividends for 6 consecutive years.


6.00%8.00%10.00%12.00%14.00%16.00%18.00%$0.00$1.00$2.00$3.00$4.00$5.00$6.00$7.0020132014201520162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM20232022202120202019201820172016201520142013
Dividend$2.34$2.56$2.56$2.44$2.40$2.40$2.40$2.40$3.00$6.70$4.20$3.49

Dividend yield

5.76%6.32%5.87%5.03%5.04%5.65%6.58%6.58%9.45%17.04%9.83%9.85%

Monthly Dividends

The table displays the monthly dividend distributions for BlackRock Health Sciences Trust. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.00$2.13
2023$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$2.56
2022$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$2.56
2021$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.21$0.21$0.21$2.44
2020$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$2.40
2019$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$2.40
2018$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$2.40
2017$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$2.40
2016$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.80$3.00
2015$0.17$0.17$0.17$0.17$0.17$0.17$0.17$0.20$0.20$0.20$0.20$4.75$6.70
2014$0.00$0.00$0.43$0.00$0.00$0.43$0.00$0.00$0.14$0.50$0.17$2.54$4.20
2013$0.38$0.00$0.00$0.38$0.00$0.00$0.38$0.00$0.00$2.34$3.49

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%5.8%
BlackRock Health Sciences Trust has a dividend yield of 5.76%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%65.0%
BlackRock Health Sciences Trust has a payout ratio of 65.04%, which is quite average when compared to the overall market. This suggests that BlackRock Health Sciences Trust strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-8.00%-6.00%-4.00%-2.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-3.25%
-0.27%
BME (BlackRock Health Sciences Trust)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the BlackRock Health Sciences Trust. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BlackRock Health Sciences Trust was 42.03%, occurring on Nov 20, 2008. Recovery took 263 trading sessions.

The current BlackRock Health Sciences Trust drawdown is 3.25%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-42.03%Jan 15, 2008217Nov 20, 2008263Dec 8, 2009480
-36.65%Feb 14, 202026Mar 23, 202073Jul 7, 202099
-25.47%Oct 3, 201856Dec 21, 2018235Nov 27, 2019291
-23.04%Aug 18, 2015123Feb 11, 2016350Jul 3, 2017473
-21.66%Jul 1, 201128Aug 10, 2011157Mar 26, 2012185

Volatility

Volatility Chart

The current BlackRock Health Sciences Trust volatility is 3.05%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
3.05%
3.75%
BME (BlackRock Health Sciences Trust)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BlackRock Health Sciences Trust over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of BlackRock Health Sciences Trust compared to its peers in the Asset Management industry.


PE Ratio
100.0200.0300.0400.0500.010.4
The chart displays the price to earnings (P/E) ratio for BME in comparison to other companies of the Asset Management industry. Currently, BME has a PE value of 10.4. This PE ratio falls in the average range for the industry.
PEG Ratio
-4.0-2.00.02.04.00.0
The chart displays the price to earnings to growth (PEG) ratio for BME in comparison to other companies of the Asset Management industry. Currently, BME has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for BlackRock Health Sciences Trust.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items